Duke Health Provider
Jerrold H. Levy, MD
Anesthesiologist
Duke Health Provider
Where I See Patients
Duke University Hospital - Durham, NC
Board Certified
American Board of Anesthesiology, General Anesthesiology
My Locations
About Me
School of Medicine Departments and Divisions
Current Appointments and Affiliations
- Professor Emeritus of Anesthesiology, Anesthesiology, Cardiothoracic 2025
- Professor in Surgery, Surgery, Cardiovascular and Thoracic Surgery 2017
Languages I Speak
English, French, Japanese, Spanish
Training and Education
Board Certification
American Board of Anesthesiology, General Anesthesiology
Fellowship
Respiratory Intensive Care, Massachusetts General Hospital, 1981-1982
Cardiac Anesthesia, Massachusetts General Hospital, 1982-1983
Residency
Internship, Internal Medicine, Jackson Memorial Hospital (Florida), 1978-1979
Anesthesia, Massachusetts General Hospital, 1979-1981 (Chief Resident, 1981-1982)
Education
MD, University of Miami Leonard M. Miller School of Medicine, 1978
Clinical Focus and Research
Publications and Grants
Grants3
Books15
Academic Articles526
Book Sections89
Conference Papers17
- Integrated Training in Anesthesiology Research awarded by National Institutes of Health 1996 - 2026
- Levy, J. H., ed. Clinics in Laboratory Medicine: Anticoagulation. Philadelphia: Elsevier, 2014.
- Levy, Jerrold H. Anaphylactic Reactions in Anesthesia and Intensive Care. Butterworth-Heinemann, 2013.
- Levy, J. H. Preface, 2011.
- Helms, Julie, Corinne Frere, Thomas Thiele, Kenichi A. Tanaka, Matthew D. Neal, Marie E. Steiner, Jean M. Connors, and Jerrold H. Levy. “Corrigendum to 'Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis.': [Journal of Thrombosis and Haemostasis (2023) Volume 21, Issue 2, February 2023, Pages 373-396].” J Thromb Haemost 23, no. 5 (May 2025): 1739. https://doi.org/10.1016/j.jtha.2025.02.021.
- Levy, Jerrold H., Joseph R. Shaw, Jean M. Connors, James Douketis, and Jeffrey I. Weitz. “Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH: reply.” J Thromb Haemost 23, no. 5 (May 2025): 1727–29. https://doi.org/10.1016/j.jtha.2025.03.010.
- Gouin-Thibault, Isabelle, Lana A. Castellucci, Jean M. Connors, Michael Hardy, Alexandre Mansour, Virginie Siguret, Corinne Frere, et al. “Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTH.” J Thromb Haemost 23, no. 5 (May 2025): 1717–26. https://doi.org/10.1016/j.jtha.2025.02.012.
- Levy, J. H. “Pharmacologic Approaches to Bleeding.” In Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, 219–22, 2024. https://doi.org/10.1016/B978-0-323-96014-4.00064-1.
- Levy, J. H. “Anticoagulation in the intensive care unit.” In Textbook of Critical Care, 1046.e1-1050.e1, 2023. https://doi.org/10.1016/B978-0-323-75929-8.00137-4.
- Levy, J. H., and R. M. Sniecinski. “Coagulopathy and Bleeding Management for Aortic Dissection Surgery.” In Aortic Dissection and Acute Aortic Syndromes, 577–93, 2021. https://doi.org/10.1007/978-3-030-66668-2_39.
- Karkouti, Keyvan, Jeannie Callum, Kenichi Tanaka, Deep Grewal, Cristina Solomon, Sigurd Knaub, Sylvia Werner, Gita Pezeshki, and Jerrold H. Levy. “A PHASE 3, RANDOMIZED, ACTIVE-CONTROL STUDY OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE VERSUS FROZEN PLASMA IN BLEEDING ADULT CARDIAC SURGERY PATIENTS.” In AMERICAN JOURNAL OF HEMATOLOGY, 100:60–61, 2024.
- Solomon, Cristina, Catrin Argyle, Jerrold H. Levy, and Sylvia Werner. “A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF HUMAN PLASMA DERIVED ANTITHROMBIN (ATENATIV) IN HEPARIN-RESISTANT CARDIAC SURGERY PATIENTS.” In AMERICAN JOURNAL OF HEMATOLOGY, 100:120–21, 2024.
- Karkouti, Keyvan, Jeannie Callum, Kenichi Tanaka, Deep Grewal, Cristina Solomon, Sigurd Knaub, Sylvia Werner, and Jerrold H. Levy. “Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients.” In Blood, 142:5515–5515. American Society of Hematology, 2023. https://doi.org/10.1182/blood-2023-186539.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
This faculty member (or a member of their immediate family) has reported outside activities with the companies or institutions listed below. This information has been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts of interest.
- Bayer Healthcare Pharmaceuticals
- Grifols
- Johnson and Johnson
- Leading Biosciences
- Merck
- Octapharma
- Takeda Pharmaceutical Co. Ltd.
- Werfen (formerly Instrumentation Laboratory)